Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

Pfizer (PFE) is positioned for another earnings beat, building on a strong history of exceeding estimates with an average surprise of 39.88% over the last two quarters, including a 33.33% surprise last reported quarter. The company's positive Zacks Earnings ESP of +2.48% combined with a Zacks Rank #3 (Hold) suggests a high probability (nearly 70%) of outperforming consensus estimates, with its next earnings report anticipated on October 29, 2024.

Analysis

Pfizer (PFE) exhibits strong quantitative signals suggesting a high probability of exceeding consensus earnings estimates in its upcoming report scheduled for October 29, 2024. The company has a demonstrated track record of positive surprises, beating estimates by an average of 39.88% over the past two quarters. Specifically, it delivered a 33.33% surprise in its most recent report with earnings of $0.60 per share versus a $0.45 estimate, and a 46.43% surprise in the prior quarter. This historical performance is supported by a forward-looking positive Zacks Earnings ESP (Expected Surprise Prediction) of +2.48%, indicating that the most recent analyst revisions are trending above the broader consensus. According to the provided research methodology, the combination of a positive ESP and the stock's current Zacks Rank #3 (Hold) has historically resulted in an earnings beat nearly 70% of the time, positioning the company favorably for an upside surprise based on these specific metrics.

Key Decisions for Investors

• For event-driven investors, the combination of a positive +2.48% Earnings ESP and a strong history of earnings beats presents a potential short-term bullish catalyst ahead of the October 29 report.
• Despite the high probability of an earnings beat, the stock's Zacks Rank of #3 (Hold) suggests a more neutral underlying outlook, warranting caution and a broader review of fundamentals beyond this single predictive metric.
• Investors should monitor for any changes to the Earnings ESP as the reporting date nears, as its predictive power is weighted towards the most recent analyst revisions.